ZOLPIDEM TARTRATE
| Brand name | EDLUAR |
|---|---|
| Active ingredient | ZOLPIDEM TARTRATE |
| Strength | 5MG |
| Dosage form | TABLET |
| Route | SUBLINGUAL |
| Modality | Small molecule |
| FDA approval | March 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9265720 | February 2031 | use U-674 |
| 9597281 | April 2027 | use U-674 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.